Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Deferasirox |
Security Level |
|
Mechanism |
Deferasirox: PHENobarbital may decrease the serum concentration of Deferasirox. |
Management |
Avoid combination when possible; if the combination must be used, consider an increase in initial deferasirox dose to 30 mg/kg, and monitor serum ferritin concentrations/clinical responses to guide further dosing. |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Deferasirox
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Deferasirox Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.